Ryo Seishima

13PUBLICATIONS
18CO-AUTHORS
Solid tumoursPredictive and prognostic markersEpidemiological modellingMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 09, 2026
Impact of Renin-Angiotensin System Inhibitors on Renal Function During Temporary Ileostomy Period in Rectal Cancer Patients: A Retrospective Cohort Study.

Yusaku Shogen, Ryo Seishima, Masayoshi Monno

|Sep 09, 2025
Nationwide Trends in Short-Term Outcomes After Low Anterior Resection for Rectal Cancer: A Pre- and Post-COVID-19 Analysis From the Japanese National Clinical Database, 2018-2023.

Ryo Seishima, Hideki Endo, Hiromichi Maeda

|May 19, 2025
Impacts of COVID-19 pandemic on short-term outcomes of low anterior resection performed in hospitals with different surgical volumes.

Hiromichi Maeda, Hideki Endo, Ryo Seishima

|May 19, 2025
Three timepoint perioperative CEA levels are a prognostic factor for recurrence after adjuvant chemotherapy in patients with Stage II and III colorectal cancer.

Shodai Mizuno, Kohei Shigeta, Ryosuke Hara

|May 19, 2025
Analysis of surgical volume and short-term outcomes for upper gastrointestinal cancer post-COVID-19: Evidence from a nationwide Japanese database.

Masashi Takeuchi, Hideki Endo, Taizo Hibi

|Feb 11, 2025
Significance of homologous recombinant deficiency as a biomarker for drug sensitivity in colorectal cancer.

Yujin Kato, Ryo Seishima, Kaoru Hattori

Pageof 3

Frequent Collaborators

6 joint publications

Taizo Hibi

6 joint publications

Hiromichi Maeda

6 joint publications

Yoshihiro Kakeji

6 joint publications

Yasuyuki Seto